The Cancer Focus Fund is an oncology-focused investment fund that invests in compelling cancer therapies at or near the FDA Phase I or II human clinical trial regimen. Its strategy involves providing financial and logistical support, including business, management, and regulatory assistance, to accelerate the development of these therapeutics, often in collaboration with the clinical trial expertise and infrastructure of UT MD Anderson Cancer Center.
100% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months.
Portfolio
2
Fund Size
$50M
Top Stage
Unknown
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Starget Pharma Inc | Series A | $18M | Feb 2026 |
 KAHR | Unknown | $46.5M | Jun 2021 |
Top Co-Investors
Last updated: 16 April 2026